Northwest Biotherapeutics, Inc. (NWBO)
0.1696
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Northwest Biotherapeutics Total Assets (Quarterly) : 76.02M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.02M |
| March 31, 2026 | 80.13M |
| December 31, 2025 | 365.98M |
| September 30, 2025 | 30.69M |
| June 30, 2025 | 29.63M |
| March 31, 2025 | 27.58M |
| December 31, 2024 | 26.81M |
| September 30, 2024 | 29.40M |
| June 30, 2024 | 28.30M |
| March 31, 2024 | 28.65M |
| December 31, 2023 | 27.94M |
| September 30, 2023 | 31.57M |
| June 30, 2023 | 28.52M |
| March 31, 2023 | 32.95M |
| December 31, 2022 | 31.40M |
| September 30, 2022 | 31.18M |
| June 30, 2022 | 27.60M |
| March 31, 2022 | 30.74M |
| December 31, 2021 | 40.24M |
| September 30, 2021 | 28.30M |
| June 30, 2021 | 28.85M |
| March 31, 2021 | 32.54M |
| December 31, 2020 | 32.98M |
| September 30, 2020 | 27.24M |
| June 30, 2020 | 14.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.193M |
| December 31, 2019 | 10.65M |
| September 30, 2019 | 10.16M |
| June 30, 2019 | 14.71M |
| March 31, 2019 | 24.48M |
| December 31, 2018 | |
| September 30, 2018 | 46.34M |
| June 30, 2018 | 48.48M |
| March 31, 2018 | 49.89M |
| December 31, 2017 | 48.91M |
| September 30, 2017 | 49.75M |
| June 30, 2017 | 47.38M |
| March 31, 2017 | 48.31M |
| December 31, 2016 | 52.91M |
| September 30, 2016 | 48.94M |
| June 30, 2016 | 51.61M |
| March 31, 2016 | 62.23M |
| December 31, 2015 | 70.80M |
| September 30, 2015 | 51.64M |
| June 30, 2015 | 64.25M |
| March 31, 2015 | 49.41M |
| December 31, 2014 | 58.44M |
| September 30, 2014 | 29.39M |
| June 30, 2014 | 12.70M |
| March 31, 2014 | 12.51M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 110.72M |
| Shareholders Equity (Quarterly) | -34.70M |
| Debt to Equity Ratio | -1.818 |
| Current Ratio | 0.0351 |
| Net Debt Paydown Yield | 0.38% |